Olympic champion SCOTT HAMILTON today announced ticket sales will go on sale May 18 for SCOTT HAMILTON & FRIENDS, the third annual Nashville Ice Show benefitting the Scott Hamilton CARES Foundation, which will take place on Sunday, November 18 at 5 pm. Grammy Award-winning music superstar SHERYL CROW will again host with Scott on this can’t miss night combining performances from the biggest names in music and the most celebrated figure skaters.
“8!!! It’s always been a significant number for me – from figure eights on the ice to ‘winks’ throughout my life so I can’t think of a better date to start ticket sales or to have the event this year than on the 18th,” said Scott. “Sheryl and I are committed to creating the ultimate celebration of cancer survivorship with the only event in the country that brings the best music artists and figure skating champions together for an unforgettable family-friendly show.”
The night will also include a return of the fan-favorite special performance by local skaters, who raise funds for the opportunity to perform in the show through the Foundation’s Sk8 to Elimin8 Cancer peer-to-peer fundraising program.
Tickets for reserved seating will start at $35 plus applicable service charges and preferred seating of $50 and $75 will be available at Bridgestone Arena Box Office and ticketmaster.com. Tickets and sponsorship packages that include an After Show Celebration at the Omni Hotel – featuring dinner, live music and a silent auction – will be available for purchase through the Foundation event page.
Proceeds from the concert benefit Scott Hamilton CARES Foundation, dedicated to changing the future of cancer by funding advanced, innovative research that treats the cancer while sparing the patient. For more information, visit ScottCARES.org. Interviews and artwork are available upon request.
About Scott Hamilton CARES Foundation:
CARES is an acronym for Cancer Alliance for Research, Education and Survivorship. The Foundation seeks to be a neutral convener between organizations, researchers, academic scientists, drug developers and others to advance new treatments. It relies on the expertise of leading institutions, clinicians, scientists and industry experts to inform and provide direction on leading innovative research projects, screening, education and survivor programs.
